MURANO update: MRD, biological subsets & safety analysis VJHemOnc – Video Journal of Hematology & HemOnc 2:43 6 years ago 36 Далее Скачать
Impacts of the MURANO study for future CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 1:10 6 years ago 147 Далее Скачать
MURANO: outcomes after the end of treatment VJHemOnc – Video Journal of Hematology & HemOnc 2:53 5 years ago 71 Далее Скачать
MURANO: five-year follow-up on venetoclax plus rituximab for CLL VJHemOnc – Video Journal of Hematology & HemOnc 6:25 3 years ago 242 Далее Скачать
MURANO update: MRD negativity in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:34 6 years ago 107 Далее Скачать
The MURANO study in CLL: 5 years on VJHemOnc – Video Journal of Hematology & HemOnc 8:04 3 years ago 269 Далее Скачать
CLL: relapsed disease, discontinuation and MRD VJHemOnc – Video Journal of Hematology & HemOnc 1:31 4 years ago 126 Далее Скачать
Venetoclax and rituximab: changing the treatment landscape in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 5:17 6 years ago 536 Далее Скачать
Results of the MURANO study for CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:12 6 years ago 288 Далее Скачать
The MURANO study: key findings VJHemOnc – Video Journal of Hematology & HemOnc 2:27 5 years ago 74 Далее Скачать
Update from MURANO trial: venetoclax-rituximab leads to slower clonal growth rate in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:25 2 years ago 207 Далее Скачать
MURANO: venetoclax + rituximab in BIRC3-mutated R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:20 4 years ago 78 Далее Скачать
Venetoclax retreatment for CLL VJHemOnc – Video Journal of Hematology & HemOnc 6:50 3 years ago 2 644 Далее Скачать
MRD: a prognostic marker in targeted therapy VJHemOnc – Video Journal of Hematology & HemOnc 3:45 5 years ago 71 Далее Скачать
Venetoclax + rituximab for R/R CLL: 7-year results of the MURANO trial VJHemOnc – Video Journal of Hematology & HemOnc 2:13 1 year ago 328 Далее Скачать
MURANO study: exciting times in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:06 6 years ago 319 Далее Скачать
Does TP53-mutated clonal size impact outcomes of CLL patients from the MURANO study? VJHemOnc – Video Journal of Hematology & HemOnc 1:54 6 years ago 170 Далее Скачать
4-year update of MURANO: venR shows sustained PFS and OS benefits versus BR VJHemOnc – Video Journal of Hematology & HemOnc 3:23 4 years ago 86 Далее Скачать
An update on two trials evaluating venetoclax in subsets of CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:19 7 years ago 562 Далее Скачать
Long-term post hoc analysis of MURANO Trial: host immune changes following VenR treatment in CLL VJHemOnc – Video Journal of Hematology & HemOnc 0:51 1 year ago 48 Далее Скачать